Evicenter
P&T meetings

Imlifidase

Kidney transplantation in highly sensitized patients

Manufacturer
Hansa Biopharma
Regulatory submission
BLA submitted December 2025
85 sources

Section 6 of 6

References

85 sources

  1. Al-Salama (2020) (opens in a new tab)
  2. Axelrod et al. (2017) (opens in a new tab)
  3. Beaudrey et al. (2025) (opens in a new tab)
  4. Bockermann et al. (2022) (opens in a new tab)
  5. Cedars-Sinai Medical Center study protocol (2016) (opens in a new tab)
  6. Chandramohan et al. (2024) (opens in a new tab)
  7. ClinicalTrials.gov NCT05753930 (opens in a new tab)
  8. Couzi et al. (2023) (opens in a new tab)
  9. Darwish et al. (2020) (opens in a new tab)
  10. Davanzo et al. (2025) (opens in a new tab)
  11. de Weerd et al. (2023) (opens in a new tab)
  12. Devriese et al. (2025) (opens in a new tab)
  13. EU Clinical Trials Register 2014-000712-34 (opens in a new tab)
  14. EU Clinical Trials Register 2016-002064-13 (opens in a new tab)
  15. European Medicines Agency Idefirix EPAR (opens in a new tab)
  16. European Medicines Agency Idefirix product information (2026) (opens in a new tab)
  17. Furian et al. (2024) (opens in a new tab)
  18. Furian et al. (2025) (opens in a new tab)
  19. Ge et al. (2020) (opens in a new tab)
  20. Guney et al. (2026) (opens in a new tab)
  21. Halleck et al. (2024) (opens in a new tab)
  22. Hamdini et al. (2026) (opens in a new tab)
  23. Hannachi et al. (2026) (opens in a new tab)
  24. Hansa Biopharma (opens in a new tab)
  25. Hansa Biopharma (opens in a new tab)
  26. Hansa Biopharma (2025) (opens in a new tab)
  27. Hansa Biopharma (2025) (opens in a new tab)
  28. Hansa Biopharma (2026) (opens in a new tab)
  29. Hansa Biopharma (2026) (opens in a new tab)
  30. Hansa Biopharma (2026) (opens in a new tab)
  31. Hansa Biopharma (2026) (opens in a new tab)
  32. Hansa Biopharma capital markets presentation (2026) (opens in a new tab)
  33. Hansa Medical (2018) (opens in a new tab)
  34. Haute Autorité de Santé (2022) (opens in a new tab)
  35. Health Research Authority (opens in a new tab)
  36. Hernández-Velasco et al. (2025) (opens in a new tab)
  37. Houp and Seifert (2025) (opens in a new tab)
  38. HRSA Organ Procurement and Transplantation Network (opens in a new tab)
  39. Huang et al. (2022) (opens in a new tab)
  40. Idefirix UK Summary of Product Characteristics (opens in a new tab)
  41. Jackson (2026) (opens in a new tab)
  42. Jackson et al. (2020) (opens in a new tab)
  43. Jaffe et al. (2025a) (opens in a new tab)
  44. Jaffe et al. (2025b) (opens in a new tab)
  45. Jordan (2025b) (opens in a new tab)
  46. Jordan et al. (2017) (opens in a new tab)
  47. Jordan et al. (2021) (opens in a new tab)
  48. Jordan et al. (2025a) (opens in a new tab)
  49. Kamar et al. (2024) (opens in a new tab)
  50. Kanbay et al. (2024) (opens in a new tab)
  51. Kapturczak et al. (2026) (opens in a new tab)
  52. Kjellman et al. (2021) (opens in a new tab)
  53. Krishnan et al. (2024) (opens in a new tab)
  54. Kuypers et al. (2025) (opens in a new tab)
  55. Lauzon et al. (2025) (opens in a new tab)
  56. Lonze (2021) (opens in a new tab)
  57. Lonze et al. (2018) (opens in a new tab)
  58. Lorant et al. (2018) (opens in a new tab)
  59. Lorant et al. (2025) (opens in a new tab)
  60. Lorant et al. (2025) (opens in a new tab)
  61. Maldonado et al. (2021) (opens in a new tab)
  62. Maldonado et al. (2023) (opens in a new tab)
  63. Mamode et al. (2022) (opens in a new tab)
  64. Mancebo et al. (2025) (opens in a new tab)
  65. Milhès et al. (2023) (opens in a new tab)
  66. National Institute of Diabetes and Digestive and Kidney Diseases (opens in a new tab)
  67. National Institute of Diabetes and Digestive and Kidney Diseases (2016) (opens in a new tab)
  68. National Institute of Diabetes and Digestive and Kidney Diseases (2018) (opens in a new tab)
  69. National Institute of Diabetes and Digestive and Kidney Diseases (2021) (opens in a new tab)
  70. NCPE (2024) (opens in a new tab)
  71. NICE TA809 (2022) (opens in a new tab)
  72. NICE TA809 (2022) (opens in a new tab)
  73. Osmani et al. (2026) (opens in a new tab)
  74. Phelan and Turner (2025) (opens in a new tab)
  75. Reuter et al. (2026a) (opens in a new tab)
  76. Reuter et al. (2026b) (opens in a new tab)
  77. Schinstock et al. (2025) (opens in a new tab)
  78. Scottish Medicines Consortium (2022) (opens in a new tab)
  79. SERB Pharmaceuticals (2026) (opens in a new tab)
  80. Swissmedic Idefirix risk management plan summary (opens in a new tab)
  81. Therapeutic Goods Administration Idefirix product information (2024) (opens in a new tab)
  82. Transplantation Society of Australia and New Zealand (2026) (opens in a new tab)
  83. Vo et al. (2013) (opens in a new tab)
  84. Welsh Kidney Network (2026) (opens in a new tab)
  85. Winstedt et al. (2015) (opens in a new tab)